Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6
Frequently Asked Questions
What is Market Cap of Provectus Biopharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Provectus Biopharmaceuticals Inc market cap is $33.5M.
What is the 52-week high for Provectus Biopharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Provectus Biopharmaceuticals Inc 52 week high is $0.1517 as of October 10, 2025.
What is the 52-week low for Provectus Biopharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Provectus Biopharmaceuticals Inc 52 week low is $0.0607 as of October 10, 2025.
What is Provectus Biopharmaceuticals Inc stock price today?
Provectus Biopharmaceuticals Inc stock price today is $0.0799.
What was Provectus Biopharmaceuticals Inc stock price yesterday?
Provectus Biopharmaceuticals Inc stock price yesterday was $0.0797.
What is the PE ratio of Provectus Biopharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Provectus Biopharmaceuticals Inc’s P/E ratio is -5.28.
What is the Price-to-Book ratio of Provectus Biopharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Provectus Biopharmaceuticals Inc P/B ratio is -5.6929.
What is the 50-day moving average of Provectus Biopharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Provectus Biopharmaceuticals Inc 50-day moving average is $0.0803.
How many employess does Provectus Biopharmaceuticals Inc has?
